17426059

Source:http://linkedlifedata.com/resource/pubmed/id/17426059

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0019829, umls-concept:C0040808, umls-concept:C0045093, umls-concept:C0078257, umls-concept:C0442967, umls-concept:C1516238, umls-concept:C1522690
pubmed:issue	6
pubmed:dateCreated	2007-6-25
pubmed:abstractText	Because of high single-agent activity and modest toxicity, we hypothesized the combination of gemcitabine (G), vinorelbine (V), and pegylated liposomal doxorubicin (D) would be an effective salvage therapy for Hodgkin's lymphoma (HL).
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/CA03927, http://linkedlifedata.com/resource/pubmed/grant/CA04326, http://linkedlifedata.com/resource/pubmed/grant/CA07968, http://linkedlifedata.com/resource/pubmed/grant/CA11789, http://linkedlifedata.com/resource/pubmed/grant/CA12046, http://linkedlifedata.com/resource/pubmed/grant/CA12449, http://linkedlifedata.com/resource/pubmed/grant/CA26806, http://linkedlifedata.com/resource/pubmed/grant/CA31946, http://linkedlifedata.com/resource/pubmed/grant/CA32291, http://linkedlifedata.com/resource/pubmed/grant/CA33601, http://linkedlifedata.com/resource/pubmed/grant/CA35113, http://linkedlifedata.com/resource/pubmed/grant/CA41287, http://linkedlifedata.com/resource/pubmed/grant/CA45389, http://linkedlifedata.com/resource/pubmed/grant/CA45808, http://linkedlifedata.com/resource/pubmed/grant/CA47642, http://linkedlifedata.com/resource/pubmed/grant/CA77440, http://linkedlifedata.com/resource/pubmed/grant/CA77597, http://linkedlifedata.com/resource/pubmed/grant/CA77651, http://linkedlifedata.com/resource/pubmed/grant/CA77658
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9007735
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Bleomycin, http://linkedlifedata.com/resource/pubmed/chemical/Dacarbazine, http://linkedlifedata.com/resource/pubmed/chemical/Deoxycytidine, http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin, http://linkedlifedata.com/resource/pubmed/chemical/Polyethylene Glycols, http://linkedlifedata.com/resource/pubmed/chemical/Vinblastine, http://linkedlifedata.com/resource/pubmed/chemical/gemcitabine, http://linkedlifedata.com/resource/pubmed/chemical/pegylated liposomal doxorubicin, http://linkedlifedata.com/resource/pubmed/chemical/vinorelbine
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	0923-7534
pubmed:author	pubmed-author:BartlettN LNL, pubmed-author:Cancer Leukemia Group B, pubmed-author:CanellosG PGP, pubmed-author:ChesonB DBD, pubmed-author:FriedbergJ WJW, pubmed-author:JohnsonJ LJL, pubmed-author:JohnsonK BKB, pubmed-author:NiedzwieckiDD, pubmed-author:ZelenetzA DAD, pubmed-author:van BesienKK
pubmed:issnType	Print
pubmed:volume	18
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1071-9
pubmed:dateRevised	2007-12-3
pubmed:meshHeading	pubmed-meshheading:17426059-Adult, pubmed-meshheading:17426059-Aged, pubmed-meshheading:17426059-Aged, 80 and over, pubmed-meshheading:17426059-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:17426059-Bleomycin, pubmed-meshheading:17426059-Dacarbazine, pubmed-meshheading:17426059-Deoxycytidine, pubmed-meshheading:17426059-Disease-Free Survival, pubmed-meshheading:17426059-Dose-Response Relationship, Drug, pubmed-meshheading:17426059-Doxorubicin, pubmed-meshheading:17426059-Hodgkin Disease, pubmed-meshheading:17426059-Humans, pubmed-meshheading:17426059-Middle Aged, pubmed-meshheading:17426059-Neutropenia, pubmed-meshheading:17426059-Patient Selection, pubmed-meshheading:17426059-Polyethylene Glycols, pubmed-meshheading:17426059-Salvage Therapy, pubmed-meshheading:17426059-Survival Analysis, pubmed-meshheading:17426059-Thrombocytopenia, pubmed-meshheading:17426059-Treatment Outcome, pubmed-meshheading:17426059-Vinblastine
pubmed:year	2007
pubmed:articleTitle	Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804.
pubmed:affiliation	Siteman Cancer Center, Washington University School of Medicine, St Louis, MO 63110, USA. nbartlet@im.wustl.edu
pubmed:publicationType	Journal Article, Clinical Trial, Phase II, Clinical Trial, Phase I, Research Support, N.I.H., Extramural